22 phenotypes from 3 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Enhotm1.1(KOMP)Vlcg/Enhotm1.1(KOMP)Vlcg C57BL/6N-Enhotm1.1(KOMP)Vlcg/MbpMmucd	decreased locomotor activity	J:211773
Enhotm1.1Butl/Enho+ B6.Cg-Enhotm1.1Butl	abnormal lipid metabolism	J:225402
	normal growth/size/body region phenotype	J:225402
	hepatic steatosis	J:225402
	impaired glucose tolerance	J:225402
	increased liver triglyceride level	J:225402
	increased percent body fat/body weight	J:225402
	preweaning lethality, incomplete penetrance	J:225402
Enhotm1.1Butl/Enhotm1.1Butl B6.Cg-Enhotm1.1Butl	abnormal lipid metabolism	J:225402
	decreased locomotor activity	J:225402
	decreased muscle cell glucose uptake	J:225402
	normal growth/size/body region phenotype	J:225402
	hepatic steatosis	J:225402
	impaired glucose tolerance	J:225402
	increased body fat mass	J:225402
	increased body weight	J:225402
	increased circulating insulin level	J:225402
	increased circulating triglyceride level	J:225402
	increased fasting circulating glucose level	J:225402
	increased liver triglyceride level	J:225402
	increased percent body fat/body weight	J:225402
	insulin resistance	J:225402
	preweaning lethality, incomplete penetrance	J:225402
Enhotm1Cmwo/Enhotm1Cmwo B6.129S1-Enhotm1Cmwo	abnormal locomotor activation	J:216870
	abnormal Purkinje cell morphology	J:216870
	normal adipose tissue phenotype	J:216870
	normal behavior/neurological phenotype	J:216870
	decreased food intake	J:216870
	decreased locomotor activity	J:216870
	normal growth/size/body region phenotype	J:216870
	normal homeostasis/metabolism phenotype	J:216870
	impaired coordination	J:216870